![](/img/cover-not-exists.png)
A Phase II Trial of Trastuzumab Combined with Irinotecan in Patients with Advanced HER2-positive Chemo-refractory Gastric Cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group OGSG1203 (HERBIS-5)
Sakai, D., Satoh, T., Kurokawa, Y., Kudo, T., Nishikawa, K., Oka, Y., Tsujinaka, T., Shimokawa, T., Doki, Y., Furukawa, H.Volume:
43
Language:
english
Journal:
Japanese Journal of Clinical Oncology
DOI:
10.1093/jjco/hyt083
Date:
August, 2013
File:
PDF, 72 KB
english, 2013